Axim Biotechnologies Inc., of New York, said its development partner, Flintshire, U.K.-based Quay Pharmaceuticals Ltd., has obtained licenses from the British Home Office to import and work with the controlled drugs that are required to continue the development of Axim's Medchew Rx pharmaceutical chewing gum's family of products.